SCHEMBL3136673

SCHEMBL3136673

[O-][Cl+3]([O-])([O-])OS(c1ccccc1)(c1ccccc1)c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 1/20 0.39
CYP1A2 P05177 1/20 0.38
PTGS2 P35354 2/20 0.38
PTGS1 P23219 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPK1 P28482 1/20 0.37
ORAI1 Q96D31 1/20 0.36
ORAI2 Q96SN7 1/20 0.36
ORAI3 Q9BRQ5 1/20 0.36
TRPV6 Q9H1D0 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
PGR P06401 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
G6PD P11413 1/20 0.35
FLT1 P17948 1/20 0.35
FLT4 P35916 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3132383 1.00 TDP1 (0.43) TDP1TSHRCYP1A2PTGS2PTGS1
SCHEMBL108184 0.89 HTR6 (0.36) TDP1TSHRPTGS2ALDH1A1KMT2A
SCHEMBL3135940 0.80 HTT (0.42) TDP1TSHRCYP1A2ALDH1A1CYP3A4
SCHEMBL3126953 0.80 ESR1 (0.39) TDP1CYP1A2PTGS2PTGS1KMT2A
SCHEMBL3139597 0.80 PKM (0.42) TSHRPTGS2PTGS1ALDH1A1MAPK1
SCHEMBL3134808 0.80 HTT (0.42) TDP1TSHRCYP1A2ALDH1A1CYP3A4
SCHEMBL3140974 0.80 PKM (0.42) TSHRPTGS2PTGS1ALDH1A1MAPK1
SCHEMBL3135189 0.77 CA4 (0.46) TDP1ALDH1A1PGRGAAL3MBTL1
SCHEMBL3144342 0.77 CA4 (0.46) TDP1ALDH1A1PGRGAAL3MBTL1
SCHEMBL3132410 0.76 ALDH1A1 (0.45) TSHRALDH1A1TRPV6KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642368-B2 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-01-05 US disclosed
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2007-04-12 US disclosed
EP-1676835-A1 PROCESS FOR PRODUCING TRIARYLSULFONIUM SALT Wako Pure Chemical Industries, Ltd. (JP) 2006-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid ARSA, HAO2, HAO1 TDP1 2913/4885TSHR 1087/4885CYP1A2 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.